About Joel Morse
Form D filings for Curavit Clinical Research from 2022 to 2024 list Joel Morse as chief executive officer and director.
Joel Morse first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Joel Morse in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joel Morse works with at each company, as listed on that company's latest Form D.
Curavit Clinical Research Corp · Form D/A, Sep 5, 2024